Pro-Dex R&D per Employee
The R&D Spending per Employee of Pro-Dex (PDEX) as of Sep 26, 2026 is 18,480.66 USD. In the previous year, R&D Spending per Employee was 20,088.40 USD — a change of -8.00% (lower).
Get this data via API
Financial Data API
R&D per Employee
18,480.66USD
YoY
-8.00%
Last updated:
The Pro-Dex R&D per Employee history
3 Years
10 Years
25 Years
Max
| YEAR | R&D per Employee | YoY |
|---|---|---|
| 18,480.66USD | -8.00% | |
| 20,088.40USD | +14.02% | |
| 17,618.78USD | +13.73% | |
| 15,491.71USD | -5.91% | |
| 16,464.09USD | 0.00% | |
| 16,464.09USD | +28.73% | |
| 12,790.06USD | +23.01% | |
| 10,397.79USD | -0.58% | |
| 10,458.56USD | +54.53% | |
| 6,767.96USD | -33.86% | |
| 10,232.04USD | +11.03% | |
| 9,215.47USD | +12.55% | |
| 8,187.85USD | — |
Pro-Dex Stock analysis
Frequently Asked Questions about Pro-Dex stock
R&D Spending per Employee of Pro-Dex is 18,480.66 USD in 2026.
R&D Spending per Employee of Pro-Dex changed from 20,088.40 USD to 18,480.66 USD, representing a -8.00% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of R&D Spending per Employee Pro-Dex since 2006 – with annual values, charts, and detailed analysis.
R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.
R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Pro-Dex historically and in real time.
Workforce — Pro-Dex
All Key Metrics — Pro-Dex
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth